These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 39224032)

  • 1. MitoAMPK inhibits the Warburg effect by MZF1-SIRT6 with glycosis related genes in NSCLC.
    Li S; He J; Zhang L; Zhao Q; Zhao S; Jiang S
    J Cell Mol Med; 2024 Sep; 28(17):e70053. PubMed ID: 39224032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIRT6 drives epithelial-to-mesenchymal transition and metastasis in non-small cell lung cancer via snail-dependent transrepression of KLF4.
    Li Z; Huang J; Shen S; Ding Z; Luo Q; Chen Z; Lu S
    J Exp Clin Cancer Res; 2018 Dec; 37(1):323. PubMed ID: 30577808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
    Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
    IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin SIRT6 suppresses cell proliferation through inhibition of Twist1 expression in non-small cell lung cancer.
    Han Z; Liu L; Liu Y; Li S
    Int J Clin Exp Pathol; 2014; 7(8):4774-81. PubMed ID: 25197348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SIRT6 regulated nucleosomal occupancy affects Hexokinase 2 expression.
    Gupta P; Sheikh T; Sen E
    Exp Cell Res; 2017 Aug; 357(1):98-106. PubMed ID: 28478957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic targeting of YY1/MZF1 axis by MZF1-uPEP inhibits aerobic glycolysis and neuroblastoma progression.
    Fang E; Wang X; Wang J; Hu A; Song H; Yang F; Li D; Xiao W; Chen Y; Guo Y; Liu Y; Li H; Huang K; Zheng L; Tong Q
    Theranostics; 2020; 10(4):1555-1571. PubMed ID: 32042322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone deacetylase SIRT6 promotes glycolysis through the HIF-1α/HK2 signaling axis and induces erlotinib resistance in non-small cell lung cancer.
    You Q; Wang J; Yu Y; Li F; Meng L; Chen M; Yang Q; Xu Z; Sun J; Zhuo W; Chen Z
    Apoptosis; 2022 Dec; 27(11-12):883-898. PubMed ID: 35915188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRMT1 promotes Warburg effect by regulating the PKM2/PKM1 ratio in non-small cell lung cancer.
    Peng L; Zhao Y; Tan J; Hou J; Jin X; Liu DX; Huang B; Lu J
    Cell Death Dis; 2024 Jul; 15(7):504. PubMed ID: 39009589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m
    Xue L; Li J; Lin Y; Liu D; Yang Q; Jian J; Peng J
    J Cell Physiol; 2021 Apr; 236(4):2649-2658. PubMed ID: 32892348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of SIRT6 is associated with poor prognosis in patients with non-small cell lung cancer.
    Zhu B; Yan Y; Shao B; Tian L; Zhou W
    J Int Med Res; 2018 Apr; 46(4):1517-1527. PubMed ID: 29363378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shikonin inhibits the Warburg effect, cell proliferation, invasion and migration by downregulating PFKFB2 expression in lung cancer.
    Sha L; Lv Z; Liu Y; Zhang Y; Sui X; Wang T; Zhang H
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34109434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Octamer transcription factor-1 induces the Warburg effect via up-regulation of hexokinase 2 in non-small cell lung cancer.
    Li Z; Su J; Sun M; Song J; Sun H; Fan J; Chen G; Shan C; Qi Q; Zhang S
    Mol Cell Biochem; 2021 Sep; 476(9):3423-3431. PubMed ID: 33970409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of SIRT6 predicts poor prognosis and promotes metastasis of non-small cell lung cancer via the ERK1/2/MMP9 pathway.
    Bai L; Lin G; Sun L; Liu Y; Huang X; Cao C; Guo Y; Xie C
    Oncotarget; 2016 Jun; 7(26):40377-40386. PubMed ID: 27777384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circ_0067934 promotes non-small cell lung cancer development by regulating miR-1182/KLF8 axis and activating Wnt/β-catenin pathway.
    Zhao M; Ma W; Ma C
    Biomed Pharmacother; 2020 Sep; 129():110461. PubMed ID: 32768951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long non‑coding RNA BCYRN1 promotes glycolysis and tumor progression by regulating the miR‑149/PKM2 axis in non‑small‑cell lung cancer.
    Lang N; Wang C; Zhao J; Shi F; Wu T; Cao H
    Mol Med Rep; 2020 Mar; 21(3):1509-1516. PubMed ID: 32016455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct HIC1-SIRT1-p53 loop deregulation in lung squamous carcinoma and adenocarcinoma patients.
    Tseng RC; Lee CC; Hsu HS; Tzao C; Wang YC
    Neoplasia; 2009 Aug; 11(8):763-70. PubMed ID: 19649206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiosensitization effect of overexpression of adenovirus-mediated SIRT6 on A549 non-small cell lung cancer cells.
    Cai Y; Sheng ZY; Liang SX
    Asian Pac J Cancer Prev; 2014; 15(17):7297-301. PubMed ID: 25227832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00511 promotes the progression of non-small cell lung cancer through downregulating LATS2 and KLF2 by binding to EZH2 and LSD1.
    Zhu FY; Zhang SR; Wang LH; Wu WD; Zhao H
    Eur Rev Med Pharmacol Sci; 2019 Oct; 23(19):8377-8390. PubMed ID: 31646568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. β-elemene suppresses Warburg effect in NCI-H1650 non-small-cell lung cancer cells by regulating the miR-301a-3p/AMPKα axis.
    Li L; Zhao D; Cheng G; Li Q; Chu Y; Chu H; Ding Y; Li C
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32463461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SIRT6 expression is associated with poor prognosis and chemosensitivity in patients with non-small cell lung cancer.
    Azuma Y; Yokobori T; Mogi A; Altan B; Yajima T; Kosaka T; Onozato R; Yamaki E; Asao T; Nishiyama M; Kuwano H
    J Surg Oncol; 2015 Aug; 112(2):231-7. PubMed ID: 26180037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.